USA Terbinafine (Lamisil) Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Terbinafine (Lamisil) market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Terbinafine (Lamisil) market. Detailed analysis of key players, along with key growth strategies adopted by Terbinafine (Lamisil) industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Smaart Pharmaceutticals

    • Auro Pharma Inc

    • Mylan Pharmaceuticals

    • Apotex Corporation

    • Novartis Pharmaceuticals Corporation

    • Teva

    • Nu Pharm

    • Sivem Pharmaceuticals

    • Qingdao Jinfeng Pharmaceutical

    • Qd Pharmaceuticals

    • Pliva

    • Pfizer

    • Pharmel Inc

    • Perrigo

    • Jamp Pharma Corporation

    • Qilu Pharmaceutical

    • Gokul Pharma

    • Codal Synto

    By Type:

    • Oral

    • External Use

    By End-User:

    • Onychomycosis

    • Bronchial Asthma

    • Gynecological Anti-infection Preparation

    • Others

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Terbinafine (Lamisil) Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Terbinafine (Lamisil) Market Size and Growth Rate of Oral from 2016 to 2027

      • 1.3.2 USA Terbinafine (Lamisil) Market Size and Growth Rate of External Use from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Terbinafine (Lamisil) Market Size and Growth Rate of Onychomycosis from 2016 to 2027

      • 1.4.2 USA Terbinafine (Lamisil) Market Size and Growth Rate of Bronchial Asthma from 2016 to 2027

      • 1.4.3 USA Terbinafine (Lamisil) Market Size and Growth Rate of Gynecological Anti-infection Preparation from 2016 to 2027

      • 1.4.4 USA Terbinafine (Lamisil) Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Terbinafine (Lamisil) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Terbinafine (Lamisil) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Terbinafine (Lamisil) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Terbinafine (Lamisil) Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Terbinafine (Lamisil) Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Terbinafine (Lamisil) by Major Types

      • 3.4.1 Market Size and Growth Rate of Oral

      • 3.4.2 Market Size and Growth Rate of External Use

    4 Segmentation of Terbinafine (Lamisil) Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Terbinafine (Lamisil) by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Terbinafine (Lamisil) in Onychomycosis

      • 4.4.2 Market Size and Growth Rate of Terbinafine (Lamisil) in Bronchial Asthma

      • 4.4.3 Market Size and Growth Rate of Terbinafine (Lamisil) in Gynecological Anti-infection Preparation

      • 4.4.4 Market Size and Growth Rate of Terbinafine (Lamisil) in Others

    5 Market Analysis by Regions

    • 5.1 USA Terbinafine (Lamisil) Production Analysis by Regions

    • 5.2 USA Terbinafine (Lamisil) Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Terbinafine (Lamisil) Landscape Analysis

    • 6.1 West USA Terbinafine (Lamisil) Landscape Analysis by Major Types

    • 6.2 West USA Terbinafine (Lamisil) Landscape Analysis by Major End-Users

    7 South USA Terbinafine (Lamisil) Landscape Analysis

    • 7.1 South USA Terbinafine (Lamisil) Landscape Analysis by Major Types

    • 7.2 South USA Terbinafine (Lamisil) Landscape Analysis by Major End-Users

    8 Middle West USA Terbinafine (Lamisil) Landscape Analysis

    • 8.1 Middle West USA Terbinafine (Lamisil) Landscape Analysis by Major Types

    • 8.2 Middle West USA Terbinafine (Lamisil) Landscape Analysis by Major End-Users

    9 Northeast USA Terbinafine (Lamisil) Landscape Analysis

    • 9.1 Northeast USA Terbinafine (Lamisil) Landscape Analysis by Major Types

    • 9.2 Northeast USA Terbinafine (Lamisil) Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Smaart Pharmaceutticals

        • 10.1.1 Smaart Pharmaceutticals Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Auro Pharma Inc

        • 10.2.1 Auro Pharma Inc Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Mylan Pharmaceuticals

        • 10.3.1 Mylan Pharmaceuticals Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Apotex Corporation

        • 10.4.1 Apotex Corporation Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Novartis Pharmaceuticals Corporation

        • 10.5.1 Novartis Pharmaceuticals Corporation Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Teva

        • 10.6.1 Teva Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Nu Pharm

        • 10.7.1 Nu Pharm Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Sivem Pharmaceuticals

        • 10.8.1 Sivem Pharmaceuticals Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Qingdao Jinfeng Pharmaceutical

        • 10.9.1 Qingdao Jinfeng Pharmaceutical Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Qd Pharmaceuticals

        • 10.10.1 Qd Pharmaceuticals Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 Pliva

        • 10.11.1 Pliva Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

      • 10.12 Pfizer

        • 10.12.1 Pfizer Company Profile and Recent Development

        • 10.12.2 Market Performance

        • 10.12.3 Product and Service Introduction

      • 10.13 Pharmel Inc

        • 10.13.1 Pharmel Inc Company Profile and Recent Development

        • 10.13.2 Market Performance

        • 10.13.3 Product and Service Introduction

      • 10.14 Perrigo

        • 10.14.1 Perrigo Company Profile and Recent Development

        • 10.14.2 Market Performance

        • 10.14.3 Product and Service Introduction

      • 10.15 Jamp Pharma Corporation

        • 10.15.1 Jamp Pharma Corporation Company Profile and Recent Development

        • 10.15.2 Market Performance

        • 10.15.3 Product and Service Introduction

      • 10.16 Qilu Pharmaceutical

        • 10.16.1 Qilu Pharmaceutical Company Profile and Recent Development

        • 10.16.2 Market Performance

        • 10.16.3 Product and Service Introduction

      • 10.17 Gokul Pharma

        • 10.17.1 Gokul Pharma Company Profile and Recent Development

        • 10.17.2 Market Performance

        • 10.17.3 Product and Service Introduction

      • 10.18 Codal Synto

        • 10.18.1 Codal Synto Company Profile and Recent Development

        • 10.18.2 Market Performance

        • 10.18.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Terbinafine (Lamisil) Market Size and Growth Rate of Oral from 2016 to 2027

    • Figure USA Terbinafine (Lamisil) Market Size and Growth Rate of External Use from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Terbinafine (Lamisil) Market Size and Growth Rate of Onychomycosis from 2016 to 2027

    • Figure USA Terbinafine (Lamisil) Market Size and Growth Rate of Bronchial Asthma from 2016 to 2027

    • Figure USA Terbinafine (Lamisil) Market Size and Growth Rate of Gynecological Anti-infection Preparation from 2016 to 2027

    • Figure USA Terbinafine (Lamisil) Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Terbinafine (Lamisil) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Terbinafine (Lamisil) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Terbinafine (Lamisil) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Terbinafine (Lamisil) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Terbinafine (Lamisil) Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Terbinafine (Lamisil)

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Terbinafine (Lamisil) by Different Types from 2016 to 2027

    • Table Consumption Share of Terbinafine (Lamisil) by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Oral

    • Figure Market Size and Growth Rate of External Use

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Terbinafine (Lamisil) by Different End-Users from 2016 to 2027

    • Table Consumption Share of Terbinafine (Lamisil) by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Onychomycosis

    • Figure Market Size and Growth Rate of Bronchial Asthma

    • Figure Market Size and Growth Rate of Gynecological Anti-infection Preparation

    • Figure Market Size and Growth Rate of Others

    • Table USA Terbinafine (Lamisil) Production by Regions

    • Table USA Terbinafine (Lamisil) Production Share by Regions

    • Figure USA Terbinafine (Lamisil) Production Share by Regions in 2016

    • Figure USA Terbinafine (Lamisil) Production Share by Regions in 2021

    • Figure USA Terbinafine (Lamisil) Production Share by Regions in 2027

    • Table USA Terbinafine (Lamisil) Consumption by Regions

    • Table USA Terbinafine (Lamisil) Consumption Share by Regions

    • Figure USA Terbinafine (Lamisil) Consumption Share by Regions in 2016

    • Figure USA Terbinafine (Lamisil) Consumption Share by Regions in 2021

    • Figure USA Terbinafine (Lamisil) Consumption Share by Regions in 2027

    • Table West USA Terbinafine (Lamisil) Consumption by Types from 2016 to 2027

    • Table West USA Terbinafine (Lamisil) Consumption Share by Types from 2016 to 2027

    • Figure West USA Terbinafine (Lamisil) Consumption Share by Types in 2016

    • Figure West USA Terbinafine (Lamisil) Consumption Share by Types in 2021

    • Figure West USA Terbinafine (Lamisil) Consumption Share by Types in 2027

    • Table West USA Terbinafine (Lamisil) Consumption by End-Users from 2016 to 2027

    • Table West USA Terbinafine (Lamisil) Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Terbinafine (Lamisil) Consumption Share by End-Users in 2016

    • Figure West USA Terbinafine (Lamisil) Consumption Share by End-Users in 2021

    • Figure West USA Terbinafine (Lamisil) Consumption Share by End-Users in 2027

    • Table South USA Terbinafine (Lamisil) Consumption by Types from 2016 to 2027

    • Table South USA Terbinafine (Lamisil) Consumption Share by Types from 2016 to 2027

    • Figure South USA Terbinafine (Lamisil) Consumption Share by Types in 2016

    • Figure South USA Terbinafine (Lamisil) Consumption Share by Types in 2021

    • Figure South USA Terbinafine (Lamisil) Consumption Share by Types in 2027

    • Table South USA Terbinafine (Lamisil) Consumption by End-Users from 2016 to 2027

    • Table South USA Terbinafine (Lamisil) Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Terbinafine (Lamisil) Consumption Share by End-Users in 2016

    • Figure South USA Terbinafine (Lamisil) Consumption Share by End-Users in 2021

    • Figure South USA Terbinafine (Lamisil) Consumption Share by End-Users in 2027

    • Table Middle West USA Terbinafine (Lamisil) Consumption by Types from 2016 to 2027

    • Table Middle West USA Terbinafine (Lamisil) Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Terbinafine (Lamisil) Consumption Share by Types in 2016

    • Figure Middle West USA Terbinafine (Lamisil) Consumption Share by Types in 2021

    • Figure Middle West USA Terbinafine (Lamisil) Consumption Share by Types in 2027

    • Table Middle West USA Terbinafine (Lamisil) Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Terbinafine (Lamisil) Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Terbinafine (Lamisil) Consumption Share by End-Users in 2016

    • Figure Middle West USA Terbinafine (Lamisil) Consumption Share by End-Users in 2021

    • Figure Middle West USA Terbinafine (Lamisil) Consumption Share by End-Users in 2027

    • Table Northeast USA Terbinafine (Lamisil) Consumption by Types from 2016 to 2027

    • Table Northeast USA Terbinafine (Lamisil) Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Terbinafine (Lamisil) Consumption Share by Types in 2016

    • Figure Northeast USA Terbinafine (Lamisil) Consumption Share by Types in 2021

    • Figure Northeast USA Terbinafine (Lamisil) Consumption Share by Types in 2027

    • Table Northeast USA Terbinafine (Lamisil) Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Terbinafine (Lamisil) Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Terbinafine (Lamisil) Consumption Share by End-Users in 2016

    • Figure Northeast USA Terbinafine (Lamisil) Consumption Share by End-Users in 2021

    • Figure Northeast USA Terbinafine (Lamisil) Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Smaart Pharmaceutticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Smaart Pharmaceutticals

    • Figure Sales and Growth Rate Analysis of Smaart Pharmaceutticals

    • Figure Revenue and Market Share Analysis of Smaart Pharmaceutticals

    • Table Product and Service Introduction of Smaart Pharmaceutticals

    • Table Company Profile and Development Status of Auro Pharma Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Auro Pharma Inc

    • Figure Sales and Growth Rate Analysis of Auro Pharma Inc

    • Figure Revenue and Market Share Analysis of Auro Pharma Inc

    • Table Product and Service Introduction of Auro Pharma Inc

    • Table Company Profile and Development Status of Mylan Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Mylan Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Mylan Pharmaceuticals

    • Table Product and Service Introduction of Mylan Pharmaceuticals

    • Table Company Profile and Development Status of Apotex Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Apotex Corporation

    • Figure Sales and Growth Rate Analysis of Apotex Corporation

    • Figure Revenue and Market Share Analysis of Apotex Corporation

    • Table Product and Service Introduction of Apotex Corporation

    • Table Company Profile and Development Status of Novartis Pharmaceuticals Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis Pharmaceuticals Corporation

    • Figure Sales and Growth Rate Analysis of Novartis Pharmaceuticals Corporation

    • Figure Revenue and Market Share Analysis of Novartis Pharmaceuticals Corporation

    • Table Product and Service Introduction of Novartis Pharmaceuticals Corporation

    • Table Company Profile and Development Status of Teva

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva

    • Figure Sales and Growth Rate Analysis of Teva

    • Figure Revenue and Market Share Analysis of Teva

    • Table Product and Service Introduction of Teva

    • Table Company Profile and Development Status of Nu Pharm

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nu Pharm

    • Figure Sales and Growth Rate Analysis of Nu Pharm

    • Figure Revenue and Market Share Analysis of Nu Pharm

    • Table Product and Service Introduction of Nu Pharm

    • Table Company Profile and Development Status of Sivem Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sivem Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Sivem Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Sivem Pharmaceuticals

    • Table Product and Service Introduction of Sivem Pharmaceuticals

    • Table Company Profile and Development Status of Qingdao Jinfeng Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Qingdao Jinfeng Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Qingdao Jinfeng Pharmaceutical

    • Figure Revenue and Market Share Analysis of Qingdao Jinfeng Pharmaceutical

    • Table Product and Service Introduction of Qingdao Jinfeng Pharmaceutical

    • Table Company Profile and Development Status of Qd Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Qd Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Qd Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Qd Pharmaceuticals

    • Table Product and Service Introduction of Qd Pharmaceuticals

    • Table Company Profile and Development Status of Pliva

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pliva

    • Figure Sales and Growth Rate Analysis of Pliva

    • Figure Revenue and Market Share Analysis of Pliva

    • Table Product and Service Introduction of Pliva

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Pharmel Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pharmel Inc

    • Figure Sales and Growth Rate Analysis of Pharmel Inc

    • Figure Revenue and Market Share Analysis of Pharmel Inc

    • Table Product and Service Introduction of Pharmel Inc

    • Table Company Profile and Development Status of Perrigo

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Perrigo

    • Figure Sales and Growth Rate Analysis of Perrigo

    • Figure Revenue and Market Share Analysis of Perrigo

    • Table Product and Service Introduction of Perrigo

    • Table Company Profile and Development Status of Jamp Pharma Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jamp Pharma Corporation

    • Figure Sales and Growth Rate Analysis of Jamp Pharma Corporation

    • Figure Revenue and Market Share Analysis of Jamp Pharma Corporation

    • Table Product and Service Introduction of Jamp Pharma Corporation

    • Table Company Profile and Development Status of Qilu Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Qilu Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Qilu Pharmaceutical

    • Figure Revenue and Market Share Analysis of Qilu Pharmaceutical

    • Table Product and Service Introduction of Qilu Pharmaceutical

    • Table Company Profile and Development Status of Gokul Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gokul Pharma

    • Figure Sales and Growth Rate Analysis of Gokul Pharma

    • Figure Revenue and Market Share Analysis of Gokul Pharma

    • Table Product and Service Introduction of Gokul Pharma

    • Table Company Profile and Development Status of Codal Synto

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Codal Synto

    • Figure Sales and Growth Rate Analysis of Codal Synto

    • Figure Revenue and Market Share Analysis of Codal Synto

    • Table Product and Service Introduction of Codal Synto


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.